Literature DB >> 7627209

Depth of penetration of the neodymium: yttrium-aluminum-garnet laser in the human prostate and clinical results of high-dose laser energy in 50 patients.

A M Shanberg1, D E Sawyer, I S Lee, L W Rodgers, L A Tansey, T Ahlering.   

Abstract

We evaluated the treatment of the human prostate with the Nd:YAG laser using a Cytocare Prolase II fiber. We utilized this first in 12 patients prior to radical prostatectomy and then appropriately serially sectioned the prostate to measure the depth of penetration. The studies clearly revealed that 60 W of power and 60 s of pulse duration gave the most consistent depth of penetration in the human prostate model. This depth of penetration averaged 2 cm in the glands that were removed. At the same time there was absolutely no evidence of damage to the neurovascular bundle or to the capsule of the prostate using the above-mentioned dosimetry regime. This study was then transferred to our initial experience in treating 50 patients with benign prostatic hypertrophy and obstructive voiding symptoms. The first 25 patients were also treated with so-called spot radiation of the prostate, whereas the second 25 patients were treated by total photoirradiation of all visible endoscopic tissue. The results reveal that both groups of patients had a fairly highly satisfactory result as measured objectively with American Urological Association (AUA) symptom scores and uroflow studies. In the latter group (photoirradiation of all visible endoscopic tissue) a significantly higher dose of laser energy was utilized and a smaller failure rate was noted on a long-term basis in patients who subsequently came to transurethral resection of the prostate (TURP) because of failure of the laser procedure.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7627209     DOI: 10.1007/bf00183618

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  10 in total

1.  The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association.

Authors:  M J Barry; F J Fowler; M P O'Leary; R C Bruskewitz; H L Holtgrewe; W K Mebust; A T Cockett
Journal:  J Urol       Date:  1992-11       Impact factor: 7.450

2.  Transurethral resection versus transurethral incision of the prostate. A prospective randomized study.

Authors:  M M Christensen; J Aagaard; P O Madsen
Journal:  Urol Clin North Am       Date:  1990-08       Impact factor: 2.241

3.  Carcinoma of penis treated with neodymium YAG laser.

Authors:  T R Malloy; A J Wein; V L Carpiniello
Journal:  Urology       Date:  1988-01       Impact factor: 2.649

4.  Neodymium-YAG laser: new treatment for urethral stricture disease.

Authors:  A M Shanberg; S A Chalfin; L A Tansey
Journal:  Urology       Date:  1984-07       Impact factor: 2.649

5.  Laser in the treatment of localized prostatic carcinoma.

Authors:  S Sander; H O Beisland
Journal:  J Urol       Date:  1984-08       Impact factor: 7.450

6.  Laser prostatectomy performed with a right angle firing neodymium:YAG laser fiber at 40 watts power setting.

Authors:  J N Kabalin
Journal:  J Urol       Date:  1993-07       Impact factor: 7.450

7.  Laser treatment of bladder carcinoma and genital condylomata.

Authors:  T R Malloy; A J Wein
Journal:  Urol Clin North Am       Date:  1987-02       Impact factor: 2.241

8.  Laser ablation of the prostate in patients with benign prostatic hypertrophy.

Authors:  A J Costello; W G Bowsher; D M Bolton; K G Braslis; J Burt
Journal:  Br J Urol       Date:  1992-06

9.  Treatment of invasive bladder cancer with a neodymium:YAG laser.

Authors:  J A Smith
Journal:  J Urol       Date:  1986-01       Impact factor: 7.450

10.  Prostatism and prostatectomy: the value of urine flow rate measurement in the preoperative assessment for operation.

Authors:  P H Abrams
Journal:  J Urol       Date:  1977-01       Impact factor: 7.450

  10 in total
  1 in total

1.  Nd-YAG laser treatment of primary and recurrent pilonidal sinus.

Authors:  Christine S Lindholt-Jensen; Jes S Lindholt; Malene Beyer; Jan S Lindholt
Journal:  Lasers Med Sci       Date:  2011-09-17       Impact factor: 3.161

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.